← Open Payments lookup

LAURA CHAMPAGNE: Open Payments

NPI 1992758684 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,994 in 99 payments from 14 companies in 2025. Trend: 2023 $3,147 · 2024 $1,680 · 2025 $1,994

Food & beverage: $1,994
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$474
E.R. Squibb & Sons, L.L.C.14$322
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$233
Neurocrine BioSciences, Inc.9$186
ABBVIE INC.9$174
Axsome Therapeutics, Inc.9$137
Janssen Pharmaceuticals, Inc5$123
Teva Pharmaceuticals USA, Inc.4$103
Lundbeck LLC4$71
Alkermes, Inc.3$48

Products named: REXULTI, COBENFY, CAPLYTA, INGREZZA, VRAYLAR, Auvelity, SPRAVATO, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.